Reuters logo
BRIEF-ValuAct reports open market purchse of 500,000 shares of Valeant Pharma
March 16, 2017 / 9:52 PM / 6 months ago

BRIEF-ValuAct reports open market purchse of 500,000 shares of Valeant Pharma

March 16 (Reuters) - Valeant Pharmaceuticals International Inc

* ValueAct Holdings LP reports open market purchse of 500,000 shares of valeant pharmaceuticals at average price of $10.88/share on March 14 - SEC filing

* ValueAct Holdings LP reports open market purchse of 2.5 million shares of Valeant Pharmaceuticals at average price of $10.81/share on March 14 Source text for Eikon: [ID:bit.ly/2nsXZ3B] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below